Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
Channeling Your Inner Resilience to Foster Return to Work and Productivity
How peak recovery mindset can make the difference in return-to-work outcomes No one is without misfo
Workers' Comp
News Release
Business Insurance: Early intervention and treatment best practice for psych claims
More than a dozen states have laws that make mental injuries compensable under certain conditions, and the workers' compensation industry is
Workers' Comp
News Release
Business Insurance: Mental health front and center in comp claims
Mental health treatment, once avoided in workers' compensation claims that did not involve a compensable psychological injury, is now on the
Workers' Comp
Podcast
Exploring the Psych Effects of COVID and Emergence of PTSD in Comp
Disability
News Release
Genex Services Becomes Ticket to Work Provider
Social Security Initiative supports and protects people with disabilities who want to reenter workforce
Workers' Comp
White Paper
Proven track records create a winning formula for injured workers’ recoveries
The coronavirus pandemic has taught us much about disparities in health care.